Tag: FDA

Complex Generic Formulations: Why Proving Bioequivalence Is So Hard

Complex generic formulations like inhalers, creams, and injectables are hard to copy because traditional bioequivalence tests don’t work. Proving they match brand drugs requires advanced science, costly reverse-engineering, and regulatory alignment - making approvals rare but critically needed.